|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.382 SEK | -8.61% |
|
-7.28% | -90.44% |
| 05-22 | Transcript : Scandion Oncology A/S, Q1 2024 Earnings Call, May 22, 2024 | |
| 05-22 | Scandion Oncology A/S Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Scandion Oncology A/S reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was DKK 7.57 million compared to DKK 9.29 million a year ago. Basic loss per share from continuing operations was DKK 0.19 compared to DKK 0.23 a year ago.
Diluted loss per share from continuing operations was DKK 0.19 compared to DKK 0.23 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -90.44% | 1.48M | |
| +16.45% | 122B | |
| +21.96% | 116B | |
| +23.73% | 27.03B | |
| -20.05% | 20.36B | |
| -16.28% | 15.91B | |
| -16.52% | 16.43B | |
| -44.35% | 15.6B | |
| +63.91% | 14.94B | |
| +2.52% | 13.59B |
SCANDION ONCOLOGY A/S 
